SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-171925
Filing Date
2020-06-18
Accepted
2020-06-18 08:38:41
Documents
12
Period of Report
2020-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d906808d8k.htm   iXBRL 8-K 37556
  Complete submission text file 0001193125-20-171925.txt   164470

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20200617.xsd EX-101.SCH 3087
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20200617_lab.xml EX-101.LAB 18907
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20200617_pre.xml EX-101.PRE 11874
11 EXTRACTED XBRL INSTANCE DOCUMENT d906808d8k_htm.xml XML 3509
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 20971302
SIC: 2834 Pharmaceutical Preparations